🔓 Unlock the full profile of Balwant Singh (Beta Drugs Limited), including verified contact details, financial insights, and professional associations.
See Balwant Singh Full Profile
From IPOs, Funding Rounds & M&A — See Who’s Behind Each Deal
Below are the ✅ Verified Contact Details to help you connect directly:
Email: bal*****@bet******.com
Mobile: 87559*****
Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)
Key Insights You Should Know About This Individual
- Balwant Singh has served as Whole Time Director at Beta Drugs Ltd, demonstrating a significant leadership role within the company.
- He has been instrumental in promoting the company's commitment to making oncology medications affordable and accessible, aligning with its mission of affordability, accessibility, and acceptability of medicines.
- Singh's tenure at Beta Drugs Ltd began in 2014, and he transitioned from Whole Time Director to Independent Non-Executive Director in 2022, highlighting his evolving role within the organization.
- He holds an educational background from DAV College, which lends credibility to his leadership and decision-making capabilities in the pharmaceutical industry.
- Throughout his career, Singh has actively contributed to the strategic direction and operational effectiveness of Beta Drugs Ltd, impacting the company’s growth in the oncology sector.
| CIN | Company Name | Designation | Date |
|---|---|---|---|
| L24230HP2005PLC028969 | Beta Drugs Limited | Whole-time director | 01 Aug 2014 |
| CIN | Company Name | Designation | Date |
|---|---|---|---|
| U24231PB1992PLC051220 | Adley Lab Limited | Director | 30 Sep 2002 |